TR200904500A2 - Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları. - Google Patents
Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları.Info
- Publication number
- TR200904500A2 TR200904500A2 TR2009/04500A TR200904500A TR200904500A2 TR 200904500 A2 TR200904500 A2 TR 200904500A2 TR 2009/04500 A TR2009/04500 A TR 2009/04500A TR 200904500 A TR200904500 A TR 200904500A TR 200904500 A2 TR200904500 A2 TR 200904500A2
- Authority
- TR
- Turkey
- Prior art keywords
- ezetimibe
- nanocrystals
- preparation
- methods
- pharmaceutical formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Abstract
Mevcut buluş, ezetimib veya famıasötik olarak uygun bır tuzunun nanokristallerinin hazırlanması için bir yöntem ve bu yöntemle hazırlanan nanokristalleri içeren ezetimib farmasötik formülasyonları ve hazırlanması ile ilgilidir.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2009/04500A TR200904500A2 (tr) | 2009-06-10 | 2009-06-10 | Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları. |
PCT/TR2010/000106 WO2010144066A1 (en) | 2009-06-10 | 2010-06-04 | Method for the preparation of ezetimib nanocrystals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2009/04500A TR200904500A2 (tr) | 2009-06-10 | 2009-06-10 | Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200904500A2 true TR200904500A2 (tr) | 2009-10-21 |
Family
ID=42740287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2009/04500A TR200904500A2 (tr) | 2009-06-10 | 2009-06-10 | Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları. |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR200904500A2 (tr) |
WO (1) | WO2010144066A1 (tr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2414529A2 (en) | 2009-04-01 | 2012-02-08 | Matrix Laboratories Ltd | Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe |
JP2014511867A (ja) * | 2011-04-18 | 2014-05-19 | 合肥貝霓医薬科技有限公司 | ジヒドロピリジン系カルシウムチャネルブロッカーの精製、及びそのナノ粒子の調製方法 |
CN103655481A (zh) * | 2012-09-18 | 2014-03-26 | 江苏柯菲平医药有限公司 | 一种依折麦布口服制剂制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US6375986B1 (en) | 2000-09-21 | 2002-04-23 | Elan Pharma International Ltd. | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
US20020115696A1 (en) | 1999-06-18 | 2002-08-22 | Yoel Kloog | Treatment of post-angioplasty restenosis and atherosclerosis with ras antagonists |
US20040115134A1 (en) | 1999-06-22 | 2004-06-17 | Elan Pharma International Ltd. | Novel nifedipine compositions |
SI1353696T1 (sl) | 2001-01-26 | 2007-04-30 | Schering Corp | Kombinacije aktivatorja(-ev) peroksisomskega proliferatorja aktivirajocega receptorja (PPAR) in inhibitorja(-ev) absorpcije sterola in oblike zdravljenja za vaskularne indikacije |
AU2003230692A1 (en) | 2002-03-20 | 2003-10-08 | Elan Pharma International Ltd. | Nanoparticulate compositions of map kinase inhibitors |
US7101576B2 (en) | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
CA2488499C (en) | 2002-06-10 | 2013-03-19 | Elan Pharma International Ltd. | Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
EA200501001A1 (ru) | 2002-12-31 | 2005-12-29 | Нектар Терапьютикс | Фармацевтический состав с нерастворимым активным агентом |
BRPI0512326A (pt) | 2004-06-21 | 2008-02-26 | Nektar Therapeutics | composições compreendendo anfotericina b, métodos e sistemas |
US20060160785A1 (en) * | 2004-12-03 | 2006-07-20 | Judith Aronhime | Ezetimibe polymorphs |
CA2604770C (en) * | 2005-04-13 | 2013-09-24 | Abbott Gmbh & Co. Kg | Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof |
US20060234996A1 (en) | 2005-04-14 | 2006-10-19 | Itai Adin | Novel crystalline form of ezetimibe and processes for the preparation thereof |
WO2007092088A1 (en) | 2005-12-28 | 2007-08-16 | Nektar Therapeutics | Compositions comprising amphotericin b |
US20070275075A1 (en) | 2006-03-06 | 2007-11-29 | Ilan Zalit | Ezetimibe compositions |
US20080085315A1 (en) * | 2006-10-10 | 2008-04-10 | John Alfred Doney | Amorphous ezetimibe and the production thereof |
CN102285906B (zh) | 2007-01-24 | 2014-11-19 | 克尔克公司 | 依泽替米贝的制备方法和其的衍生物 |
WO2008092057A2 (en) * | 2007-01-26 | 2008-07-31 | Isp Investments Inc. | Formulation process method to produce spray dried products |
WO2008101723A2 (en) | 2007-02-23 | 2008-08-28 | Krka | Pharmaceutical composition containing a cholesterol absorption inhibitor |
WO2009016358A2 (en) * | 2007-07-27 | 2009-02-05 | Cipla Limited | Pharmaceutical compositions and process for making them |
-
2009
- 2009-06-10 TR TR2009/04500A patent/TR200904500A2/tr unknown
-
2010
- 2010-06-04 WO PCT/TR2010/000106 patent/WO2010144066A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010144066A1 (en) | 2010-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122853T1 (el) | Σταθερα σκευασματα λινακλοτιδης | |
CY1121742T1 (el) | Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων | |
EA201390203A1 (ru) | Способы получения тубулизинов | |
MX361218B (es) | Análogos de spliceostatina. | |
EA201270722A1 (ru) | Формы рифаксимина и их применение | |
UA111717C2 (uk) | Склад для перорального введення і ліпофільні солі метилналтрексону | |
CO6741203A2 (es) | Derivados de biciclo[3,2,1]octilamida y sus usos | |
AU2010233994A8 (en) | Bispecific anti-ErbB-3/anti-c-Met antibodies | |
EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
CY1115556T1 (el) | Φαρμακευτικη συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει ετεξιλικη δαβιγατρανη | |
EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
EA201291050A1 (ru) | Комбинация лекарств с протеинсвязывающими пролекарствами | |
EA201291211A1 (ru) | Фармацевтические композиции, содержащие гидроморфон и налоксон | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
BR112014002845A2 (pt) | composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto | |
UA118562C2 (uk) | Модулятори рецептора cxcr7 | |
CR20120146A (es) | Derivados de espirolactama y usos de los mismos | |
TR200904500A2 (tr) | Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları. | |
EA201590752A1 (ru) | Препараты производных пиримидиндиона | |
EA201190282A1 (ru) | Фармацевтическая композиция, содержащая тамсулозин | |
TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
GT201300307A (es) | "derivados de pirazol útiles como inhibidores de aldosterona sintasa" |